[144] John Wiley & Sons, Inc. SEC Filing

Rhea-AI Filing Summary

John Wiley & Sons, Inc. (WLYB) filed a Form 144 indicating a proposed sale of 5,300 common shares through UBS Financial Services on the NYSE, with an aggregate market value of $229,490. The filing lists seven tranches of stock acquired through the lapse of performance- and restricted-stock units (PSUs/RSUs) between 30-Jun-2024 and 30-Apr-2025. No prior sales were reported during the last three months.

The shares to be sold represent only 5,300 of the company’s 44,624,949 shares outstanding, a fraction that is immaterial to the public float. The notice certifies that the seller is not in possession of undisclosed material adverse information and that the trade is scheduled for approximately 02-Jul-2025.

• Issuer: John Wiley & Sons, Inc.
• Form: 144 – Notice of Proposed Sale under Rule 144
• Broker: UBS Financial Services, Weehawken, NJ
• Method: Ordinary market sale on NYSE
• Seller holdings source: PSU/RSU lapses; not gifts or open-market purchases

This filing is routine for insiders seeking to resell shares obtained via equity compensation and, given the small size relative to total shares outstanding, is unlikely to have a material impact on WLYB’s capital structure or market liquidity.

Positive

• Transparent compliance with Rule 144 and potential 10b5-1 procedures reinforces sound corporate governance.
• Immaterial volume (5,300 shares vs. 44.6 million outstanding) minimises dilution or price pressure concerns.

Negative

• Insider selling, even at a small scale, can be interpreted as a mild negative sentiment signal.
• Cash realisation of $229,490 removes alignment-through-ownership for the selling insider, albeit marginally.

Insights

Securities Analyst

TL;DR: Small insider resale (5,300 shares, $229K) from PSU/RSU vesting; negligible float impact, sentiment mildly negative.

The Form 144 reveals a limited insider transaction—5,300 shares versus 44.6 million outstanding—proposed for 2 Jul 2025. Because the stock was earned via incentive plans, the sale appears to be routine diversification rather than a strategic exit. Liquidity impact is de minimis, but investors often view any insider sale as a minor bearish signal. No other sales in the past three months reduces aggregation risk. Overall, I regard the disclosure as neutral-to-slightly-negative, largely for signalling reasons rather than fundamentals.

Corporate Governance Expert

TL;DR: Filing signals compliance; planned Rule 144 sale is ordinary, governance posture intact.

The filer followed Rule 144 disclosure protocols, affirming the absence of undisclosed adverse information and referencing potential 10b5-1 planning. Such transparency supports governance best practices. Sale size is below Rule 144 volume thresholds and below 0.02% of shares outstanding, indicating no control change or significant insider off-loading. From a governance standpoint, this is a non-event beyond routine reporting.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	UBS Financial Services Inc 1000 Harbor Blvd 3rd Floor Weehawken NJ 07086	5300	229490	44624949	07/02/2025	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	06/30/2024	PSU Lapse	John Wiley & Sons, Inc.			263	07/02/2025	N/A
Common	06/30/2024	PSU Lapse	John Wiley & Sons, Inc.			675	07/02/2025	N/A
Common	04/30/2025	RSU Lapse	John Wiley & Sons, Inc.			305	07/02/2025	N/A
Common	04/30/2025	RSU Lapse	John Wiley & Sons, Inc.			769	07/02/2025	N/A
Common	04/30/2025	RSU Lapse	John Wiley & Sons, Inc.			1637	07/02/2025	N/A
Common	04/30/2025	RSU Lapse	John Wiley & Sons, Inc.			1651	07/02/2025	N/A

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks

Date of Notice

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

How many WLYB shares are being sold under this Form 144?

5,300 common shares are slated for sale.

What is the total market value of the shares to be sold?

The aggregate market value reported is $229,490.

When is the proposed sale date for the WLYB shares?

The filing lists an approximate sale date of 02-Jul-2025.

What percentage of WLYB’s outstanding shares does the sale represent?

The 5,300 shares represent approximately 0.012% of the 44,624,949 shares outstanding.

How were the shares originally acquired?

All shares derive from the lapse of PSUs and RSUs granted by John Wiley & Sons, Inc.

Which broker will execute the transaction?

The filing designates UBS Financial Services Inc., Weehawken, NJ.